MX376951B - Forma de dosis farmacéutica de cápsula de gelatina blanda. - Google Patents
Forma de dosis farmacéutica de cápsula de gelatina blanda.Info
- Publication number
- MX376951B MX376951B MX2015012075A MX2015012075A MX376951B MX 376951 B MX376951 B MX 376951B MX 2015012075 A MX2015012075 A MX 2015012075A MX 2015012075 A MX2015012075 A MX 2015012075A MX 376951 B MX376951 B MX 376951B
- Authority
- MX
- Mexico
- Prior art keywords
- dosage form
- gelatin capsule
- soft gelatin
- pharmaceutical dosage
- neutralizing agent
- Prior art date
Links
- 239000002552 dosage form Substances 0.000 title abstract 3
- 239000007903 gelatin capsule Substances 0.000 title abstract 3
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 230000003472 neutralizing effect Effects 0.000 abstract 2
- 108010010803 Gelatin Proteins 0.000 abstract 1
- 239000002202 Polyethylene glycol Substances 0.000 abstract 1
- 229920002125 Sokalan® Polymers 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 238000004090 dissolution Methods 0.000 abstract 1
- 229920000159 gelatin Polymers 0.000 abstract 1
- 239000008273 gelatin Substances 0.000 abstract 1
- 235000019322 gelatine Nutrition 0.000 abstract 1
- 235000011852 gelatine desserts Nutrition 0.000 abstract 1
- 239000004014 plasticizer Substances 0.000 abstract 1
- 239000004584 polyacrylic acid Substances 0.000 abstract 1
- 229920001223 polyethylene glycol Polymers 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 125000000467 secondary amino group Chemical class [H]N([*:1])[*:2] 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
- A61K9/4825—Proteins, e.g. gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361794813P | 2013-03-15 | 2013-03-15 | |
| PCT/US2014/027093 WO2014152226A1 (en) | 2013-03-15 | 2014-03-14 | Pharmaceutical soft gelatin capsule dosage form |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2015012075A MX2015012075A (es) | 2016-05-10 |
| MX376951B true MX376951B (es) | 2025-03-07 |
Family
ID=50391548
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2015012075A MX376951B (es) | 2013-03-15 | 2014-03-14 | Forma de dosis farmacéutica de cápsula de gelatina blanda. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20140271837A1 (enExample) |
| EP (1) | EP2968183B1 (enExample) |
| JP (1) | JP6335269B2 (enExample) |
| CN (1) | CN105392476B (enExample) |
| AU (1) | AU2014240039B2 (enExample) |
| CA (1) | CA2906619C (enExample) |
| ES (1) | ES2681982T3 (enExample) |
| HK (1) | HK1220113A1 (enExample) |
| IL (1) | IL242438B (enExample) |
| MX (1) | MX376951B (enExample) |
| WO (1) | WO2014152226A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3031628B2 (ja) | 1990-04-07 | 2000-04-10 | 株式会社日立製作所 | 洗濯乾燥機 |
| JP3143355B2 (ja) | 1995-03-28 | 2001-03-07 | 三洋電機株式会社 | 遠心脱水装置 |
| US10673198B2 (en) | 2016-09-29 | 2020-06-02 | Nlight, Inc. | Fiber-coupled laser with time varying beam characteristics |
| US10673199B2 (en) | 2016-09-29 | 2020-06-02 | Nlight, Inc. | Fiber-based saturable absorber |
| US10673197B2 (en) | 2016-09-29 | 2020-06-02 | Nlight, Inc. | Fiber-based optical modulator |
| CA3201467A1 (en) * | 2020-11-13 | 2022-05-19 | Pfizer Inc. | Talazoparib soft gelatin capsule dosage form |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK242083D0 (da) * | 1983-05-27 | 1983-05-27 | Hansens Chr Bio Syst | Vaginalkapsler |
| US5102666A (en) * | 1990-09-11 | 1992-04-07 | Oramed, Inc. | Calcium polycarbophil controlled release composition and method |
| IT1275816B1 (it) * | 1995-10-27 | 1997-10-17 | Montefarmaco Spa | Composizioni farmaceutiche solide per uso vaginale |
| AU1925697A (en) * | 1996-03-12 | 1997-10-01 | Novartis Ag | Filled gelatin capsules having a reduced degree of cross-linking |
| US20040131670A1 (en) * | 2001-04-17 | 2004-07-08 | Ping Gao | Pellicle-resistant gelatin capsule |
| WO2005070950A1 (en) | 2004-01-15 | 2005-08-04 | Warner Chilcott Company, Inc. | Di-steroidal prodrugs of ethinyl estradiol |
| MXPA06007852A (es) | 2004-01-15 | 2007-01-31 | Warner Chilcott Co Inc | Profarmacos di-esteroidales de estradiol. |
| CA2612380C (en) | 2005-06-16 | 2017-06-06 | Warner Chilcott Company, Inc. | Estrogen compositions for vaginal administration |
| WO2007008474A2 (en) | 2005-07-12 | 2007-01-18 | Warner Chilcott Company, Inc. | 3 -ester prodrugs of estradiol |
| ES2523045T3 (es) | 2005-07-12 | 2014-11-20 | Warner Chilcott Company, Llc | Derivado éster de etinil estradiol |
| WO2007050975A2 (en) * | 2005-10-26 | 2007-05-03 | Banner Pharmacaps, Inc. | Hydrophilic vehicle-based dual controlled release matrix system as capsule fill |
| US20070104778A1 (en) * | 2005-11-07 | 2007-05-10 | Hongxia Zeng | Controlled-release emulsion compositions |
| EP2011496A1 (en) * | 2007-07-03 | 2009-01-07 | Indena S.P.A. | Combinations of vasoactive substances with estrogens and their use in the treatment of female sexual dysfunctions |
-
2014
- 2014-03-14 EP EP14714141.0A patent/EP2968183B1/en active Active
- 2014-03-14 CN CN201480022801.6A patent/CN105392476B/zh active Active
- 2014-03-14 HK HK16108115.5A patent/HK1220113A1/zh unknown
- 2014-03-14 US US14/210,630 patent/US20140271837A1/en not_active Abandoned
- 2014-03-14 AU AU2014240039A patent/AU2014240039B2/en active Active
- 2014-03-14 CA CA2906619A patent/CA2906619C/en active Active
- 2014-03-14 ES ES14714141.0T patent/ES2681982T3/es active Active
- 2014-03-14 MX MX2015012075A patent/MX376951B/es active IP Right Grant
- 2014-03-14 WO PCT/US2014/027093 patent/WO2014152226A1/en not_active Ceased
- 2014-03-14 JP JP2016502332A patent/JP6335269B2/ja active Active
-
2015
- 2015-11-04 IL IL242438A patent/IL242438B/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| CN105392476A (zh) | 2016-03-09 |
| MX2015012075A (es) | 2016-05-10 |
| CA2906619A1 (en) | 2014-09-25 |
| WO2014152226A1 (en) | 2014-09-25 |
| IL242438B (en) | 2020-01-30 |
| US20140271837A1 (en) | 2014-09-18 |
| CN105392476B (zh) | 2018-11-02 |
| AU2014240039A1 (en) | 2015-10-15 |
| EP2968183A1 (en) | 2016-01-20 |
| EP2968183B1 (en) | 2018-05-09 |
| JP6335269B2 (ja) | 2018-05-30 |
| AU2014240039B2 (en) | 2019-01-24 |
| JP2016513680A (ja) | 2016-05-16 |
| CA2906619C (en) | 2021-11-16 |
| ES2681982T3 (es) | 2018-09-17 |
| HK1220113A1 (zh) | 2017-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX376951B (es) | Forma de dosis farmacéutica de cápsula de gelatina blanda. | |
| MX2019007956A (es) | Liberacion autorregulada de ingrediente farmaceutico activo. | |
| EA201500742A1 (ru) | Защищенные от нецелевого использования фармацевтические композиции | |
| CL2017003437A1 (es) | Formulación solida oral que contiene irinotecán y método de preparación de la misma | |
| UY35859A (es) | ?combinación farmacéutica que comprende amlodipina, losartán y rosuvastatina?. | |
| MX2017003082A (es) | Composiciones farmaceuticas resistentes al abuso. | |
| CY1122387T1 (el) | Διπλης χρησης δισκια στοματικης φαρμακευτικης συνθεσης θειικων αλατων και μεθοδοι χρησης αυτων | |
| EA201690679A1 (ru) | Стабильная фармацевтическая композиция, содержащая амлодипин и валсартан | |
| AR092151A1 (es) | Preparacion farmaceutica solida que contiene levotiroxina | |
| MX2017013636A (es) | Combinacion de dosis fija resistente a la manipulacion que proporciona una liberacion rapida de dos farmacos desde diferentes particulas. | |
| MX2019004554A (es) | Forma de dosis farmaceutica de capsula de gelatina blanda con goma guar modificada. | |
| CL2015002817A1 (es) | Formulación del l-5-metiltetrahidrofolato de calcio amorfo (l-5-mthf-ca). | |
| EA201501164A1 (ru) | Твердая фармацевтическая лекарственная форма | |
| SI3060203T1 (en) | A effervescent tablet containing a high level of aspirin | |
| MX2016014256A (es) | Formulaciones y metodos para el suministro vaginal de antiprogestinas. | |
| CL2016000182A1 (es) | Composición farmacéutica anti-tuberculosis estable en una forma de un comprimido recubierto que comprende gránulos de isoniazid y gránulos de rifapentina y su proceso de preparación | |
| GEP201706743B (en) | Oral formulation for the treatment of cardiovascular diseases | |
| UY35690A (es) | Composiciones farmacéuticas de ranolazina y dronedarona | |
| CL2016002655A1 (es) | Composición farmacéutica para el tratamiento de alopatías relacionadas con el dolor, usando como agente activo al ketorolaco trometamina y clorhidrato de tramadol | |
| UY35324A (es) | Composiciones farmacéuticas que contienen dexketoprofeno y tramadol | |
| GEP201606594B (en) | Pharmaceutical composition of sedative and spasmolytic action in soft gelatin capsules (variations) | |
| PH12020550597A1 (en) | Formulation having improved hygroscopic property and dissolution rate comprising telmisartan or its pharmaceutically acceptable salt | |
| CO2019004796A2 (es) | Preparación de complejo farmacéutica que comprende amlodipina, losartán y rosuvastatina | |
| DOP2019000233A (es) | Dropropizina en combinacion con ambroxol en la forma farmaceutica de jarabe y tableta | |
| MX2018007976A (es) | Formulacion de combinacion farmaceutica. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration | ||
| PD | Change of proprietorship |
Owner name: ALLERGAN THERAPEUTICS LLC |